Mutasem Rawas-Qalaji

Title: Innovations by Mutasem Rawas-Qalaji

Introduction

Mutasem Rawas-Qalaji is an accomplished inventor based in Sharjah, United Arab Emirates. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the delivery and effectiveness of medications.

Latest Patents

One of his notable patents is for the formulation of atropine sulfate rapidly-disintegrating sublingual tablets. This invention provides atropine sulfate (AS) rapidly-disintegrating sublingual tablets (RDSTs) of improved formulation in a sublingual dosage form. The AS RDSTs are designed for therapeutic use in the treatment of organophosphate (OP) exposure and acute toxicity. This innovative dosage form offers an alternative, easy-to-use method for managing organophosphate toxicity. Additionally, the invention includes methods for improved formulation and quality evaluation of the atropine sulfate rapidly-disintegrating sublingual tablets. He holds 1 patent for this groundbreaking work.

Career Highlights

Mutasem Rawas-Qalaji is affiliated with the University of Sharjah, where he contributes to research and development in the pharmaceutical sciences. His academic background and research experience have positioned him as a key figure in the field of drug formulation.

Collaborations

He collaborates with Rawan S Bafail, working together to advance their research initiatives and contribute to the scientific community.

Conclusion

Mutasem Rawas-Qalaji's innovative work in developing atropine sulfate rapidly-disintegrating sublingual tablets showcases his commitment to improving medical treatments. His contributions are significant in addressing critical health issues related to organophosphate toxicity.